← Open Payments lookup

KAMESHA MOULTRY: Open Payments

NPI 1649727850 · OZARK, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,144 in 54 payments from 10 companies in 2025. Trend: 2023 $89 · 2024 $664 · 2025 $1,144

Food & beverage: $1,144
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.15$319
Vanda Pharmaceuticals Inc.13$278
Otsuka America Pharmaceutical, Inc.9$191
Alkermes, Inc.4$88
Teva Pharmaceuticals USA, Inc.4$87
Janssen Pharmaceuticals, Inc3$73
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$63
Lundbeck LLC1$15
Luye Pharma (USA) Ltd.1$15
E.R. Squibb & Sons, L.L.C.1$15

Products named: INGREZZA, FANAPT, REXULTI, ARISTADA, AUSTEDO XR, INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA.

Industry payments across AL — which companies pay providers there.